Maternal RSV vaccination enhances antibody transfer to newborns, with optimal transfer efficiency observed when given at ...

Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.

Most discontinued anti-tau antibodies (red) targeted tau’s N-terminus. Of the antibodies currently in trials (green), bepranemab and E2814 presented results at CTAD, while JJ-63733657/posdinemab and ...

Although the media and the public are worried about the infectious risks of transfusion, hemovigilance reports show that antigen-antibody ... the wrong blood to a patient (e.g. group A blood ...

Lecanemab, marketed as Leqembi, is the first drug targeting the root cause of Alzheimer’s disease to be approved by the ...

Treatment with the anti-TIGIT antibody vibostolimab and Keytruda (pembrolizumab ... Common treatment-related side effects in ...

Here are the morning's top stories on Tuesday, November 19, 2024… If you’re one of the unlucky people who get bitten by a ...

While countless long COVID sufferers put Pretorius’s theory to the test, her new focus is raising its awareness. Not only ...

Anti-amyloid antibodies lecanemab and donanemab are in clinical use now, but that does not mean research on them has stopped. At the Clinical Trials on Alzheimer’s Disease conference, held October ...

Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting ...

Treatment with Vaccinex's pepinemab antibody to SEMA4D slowed expression of key biomarkers of disease progression, including blood levels of glial fibrillary ... which had the effect of reducing group ...